Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.

Evaluation of Glycaemic Control After Initiation of Levemir® in Patients With Type 2 Diabetes Mellitus and Time Period Between Diagnosis of Type 2 Diabetes Mellitus and Insulin Initiation.

This study is conducted in Europe. The aim of this observational study is to observe the efficacy of Levemir® treatment in patients with type 2 diabetes in everyday clinical practice in Switzerland. Furthermore the time period between diagnosis of type 2 diabetes and insulin initiation is evaluated.

Inclusion Criteria:

• Patients with type 2 diabetes mellitus
• Insulin-naive or currently treated with another basal insulin
• Inclusion of patients at the discretion of the treating physician after the decision to prescribe Levemir®

Exclusion Criteria:

• Type 1 diabetes mellitus
• Patients treated with short acting or with premix insulin
• Women who are pregnant, breast feeding or have the intention to become pregnant
• Known or suspected allergy to the study product or related product
• Any exclusion criteria according to the Swiss Levemir® SPC (Summary of Product Characteristics)